Upgrade to SI Premium - Free Trial

William Blair stays Outperform on Ionis Pharmaceuticals (IONS); pricing update 'positive'

March 25, 2026 5:45 PM
William Blair analyst Myles Minter reiterated an Outperform rating on Ionis Pharmaceuticals (NASDAQ: IONS)The analyst commented, "We view today’s pricing ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments